These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34646269)

  • 1. Potential Therapeutic Applications of Pulmonary Surfactant Lipids in the Host Defence Against Respiratory Viral Infections.
    Ji J; Sun L; Luo Z; Zhang Y; Xianzheng W; Liao Y; Tong X; Shan J
    Front Immunol; 2021; 12():730022. PubMed ID: 34646269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alveolar type II cells and pulmonary surfactant in COVID-19 era.
    Calkovska A; Kolomaznik M; Calkovsky V
    Physiol Res; 2021 Dec; 70(S2):S195-S208. PubMed ID: 34913352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-inflammatory and antiviral properties of anionic pulmonary surfactant phospholipids.
    Numata M; Kandasamy P; Voelker DR
    Immunol Rev; 2023 Aug; 317(1):166-186. PubMed ID: 37144896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury.
    Cattel F; Giordano S; Bertiond C; Lupia T; Corcione S; Scaldaferri M; Angelone L; De Rosa FG
    Respir Physiol Neurobiol; 2021 Jun; 288():103645. PubMed ID: 33657448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidences suggesting a possible role of Vitamin D in COVID 19: The missing link.
    Singh S; Singh CM; Ranjan A; Kumar S; Singh DK
    Indian J Pharmacol; 2021; 53(5):394-402. PubMed ID: 34854410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections.
    Han S; Mallampalli RK
    Ann Am Thorac Soc; 2015 May; 12(5):765-74. PubMed ID: 25742123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory and anti-viral actions of anionic pulmonary surfactant phospholipids.
    Numata M; Voelker DR
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jun; 1867(6):159139. PubMed ID: 35240310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling the enigma: The emerging significance of pulmonary surfactant proteins in predicting, diagnosing, and managing COVID-19.
    Bastani MN; Jalilian S
    Immun Inflamm Dis; 2024 Jun; 12(6):e1302. PubMed ID: 38860749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host defence capacities of pulmonary surfactant: evidence for 'non-surfactant' functions of the surfactant system.
    Pison U; Max M; Neuendank A; Weissbach S; Pietschmann S
    Eur J Clin Invest; 1994 Sep; 24(9):586-99. PubMed ID: 7828630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoring pulmonary surfactant membranes and films at the respiratory surface.
    Echaide M; Autilio C; Arroyo R; Perez-Gil J
    Biochim Biophys Acta Biomembr; 2017 Sep; 1859(9 Pt B):1725-1739. PubMed ID: 28341439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell responses and therapies against SARS-CoV-2 infection.
    Toor SM; Saleh R; Sasidharan Nair V; Taha RZ; Elkord E
    Immunology; 2021 Jan; 162(1):30-43. PubMed ID: 32935333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylglycerol and surfactant: A potential treatment for COVID-19?
    Bollag WB; Gonzales JN
    Med Hypotheses; 2020 Nov; 144():110277. PubMed ID: 33254581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights Gained Into the Treatment of COVID19 by Pulmonary Surfactant and Its Components.
    Li D; Wang X; Liao Y; Wang S; Shan J; Ji J
    Front Immunol; 2022; 13():842453. PubMed ID: 35592339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary surfactant itself must be a strong defender against SARS-CoV-2.
    Takano H
    Med Hypotheses; 2020 Nov; 144():110020. PubMed ID: 32590326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects.
    Seeger W; Günther A; Walmrath HD; Grimminger F; Lasch HG
    Clin Investig; 1993 Mar; 71(3):177-90. PubMed ID: 8481620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial.
    Dushianthan A; Clark H; Madsen J; Mogg R; Matthews L; Berry L; de la Serna JB; Batchelor J; Brealey D; Hussell T; Porter J; Djukanovic R; Feelisch M; Postle A; Grocott MPW
    Trials; 2020 Dec; 21(1):1014. PubMed ID: 33302976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anionic Pulmonary Surfactant Lipid Treatment Inhibits Rhinovirus A Infection of the Human Airway Epithelium.
    Numata M; Sajuthi S; Bochkov YA; Loeffler J; Everman J; Vladar EK; Cooney RA; Reinhardt RL; Liu AH; Seibold MA; Voelker DR
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung Surfactant Lipids Provide Immune Protection Against
    García-Fojeda B; González-Carnicero Z; de Lorenzo A; Minutti CM; de Tapia L; Euba B; Iglesias-Ceacero A; Castillo-Lluva S; Garmendia J; Casals C
    Front Immunol; 2019; 10():458. PubMed ID: 30936871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.
    Blaess M; Kaiser L; Sommerfeld O; Csuk R; Deigner HP
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary Surfactant: A Unique Biomaterial with Life-saving Therapeutic Applications.
    Pioselli B; Salomone F; Mazzola G; Amidani D; Sgarbi E; Amadei F; Murgia X; Catinella S; Villetti G; De Luca D; Carnielli V; Civelli M
    Curr Med Chem; 2022; 29(3):526-590. PubMed ID: 34525915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.